Literature DB >> 16757336

The RIN family of Ras effectors.

Joanne M Bliss1, Byrappa Venkatesh, John Colicelli.   

Abstract

The human RIN1 gene was first identified as a cDNA fragment that interfered with RAS-induced phenotypes in the yeast Saccharomyces cerevisiae. Subsequent analysis of full-length RIN1 clones showed that the protein product of this gene is a downstream effector of RAS and binds with high affinity and specificity to activated HRAS. Two downstream RIN1 effector pathways have been described. The first involves direct activation of RAB5-mediated endocytosis. The second involves direct activation of ABL tyrosine kinase activity. Importantly, each of these distinct RIN1 functions is enhanced by activated RAS, suggesting that RIN1 represents a unique class of RAS effector connected to two independent signaling pathways. In this chapter, we summarize our assays and approaches for evaluating the biochemistry and biology of RIN1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757336     DOI: 10.1016/S0076-6879(05)07028-X

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  8 in total

1.  A tale of three GTPases and a RIN in endothelial cell adhesion.

Authors:  Mar Fernandez-Borja
Journal:  Cell Res       Date:  2012-08-14       Impact factor: 25.617

2.  RIN1 exhibits oncogenic property to suppress apoptosis and its aberrant accumulation associates with poor prognosis in melanoma.

Authors:  Ping Fang; Zigang Zhao; Hongfang Tian; Xin Zhang
Journal:  Tumour Biol       Date:  2012-05-25

3.  Overexpression of RIN1 associates with tumor grade and progression in patients of bladder urothelial carcinoma.

Authors:  Guang-yi Shan; Zhe Zhang; Qi-guang Chen; Xiu-yue Yu; Guo-bin Liu; Chui-ze Kong
Journal:  Tumour Biol       Date:  2012-01-17

4.  Regulation of cell migration and morphogenesis by Abl-family kinases: emerging mechanisms and physiological contexts.

Authors:  William D Bradley; Anthony J Koleske
Journal:  J Cell Sci       Date:  2009-10-01       Impact factor: 5.285

Review 5.  Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer.

Authors:  Laura C Kelley; Sohrab Shahab; Scott A Weed
Journal:  Clin Exp Metastasis       Date:  2008-03-07       Impact factor: 5.150

6.  A novel protein kinase D phosphorylation site in the tumor suppressor Rab interactor 1 is critical for coordination of cell migration.

Authors:  Susanne Ziegler; Tim Eiseler; Rolf-Peter Scholz; Alexander Beck; Gisela Link; Angelika Hausser
Journal:  Mol Biol Cell       Date:  2011-01-05       Impact factor: 4.138

7.  Targeted sequencing of the Paget's disease associated 14q32 locus identifies several missense coding variants in RIN3 that predispose to Paget's disease of bone.

Authors:  Mahéva Vallet; Dinesh C Soares; Sachin Wani; Antonia Sophocleous; Jon Warner; Donald M Salter; Stuart H Ralston; Omar M E Albagha
Journal:  Hum Mol Genet       Date:  2015-02-20       Impact factor: 6.150

8.  Usp9x regulates Ets-1 ubiquitination and stability to control NRAS expression and tumorigenicity in melanoma.

Authors:  Harish Potu; Luke F Peterson; Malathi Kandarpa; Anupama Pal; Hanshi Sun; Alison Durham; Paul W Harms; Peter C Hollenhorst; Ugur Eskiocak; Moshe Talpaz; Nicholas J Donato
Journal:  Nat Commun       Date:  2017-02-15       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.